Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 74.45
-0.25 (-0.33%)
Aug 19, 2025, 11:45 AM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 22.01 billion as of August 18, 2025. Its market cap has increased by 161.28% in one year.
Market Cap
22.01B
Enterprise Value
20.51B
Revenue
455.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
74.45
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has increased from 18.43B to 22.01B, an increase of 19.42%. That is a compound annual growth rate of 4.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 22.01B | 158.41% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
| Jul 8, 2021 | 18.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 276.65B |
| Hansoh Pharmaceutical Group Company | 221.78B |
| JD Health International | 196.01B |
| Innovent Biologics | 166.99B |
| Akeso | 148.55B |
| Sino Biopharmaceutical | 139.86B |
| WuXi Biologics | 125.94B |
| CSPC Pharmaceutical Group | 125.31B |